No Detail Found!

Post-Neutralisation Activated Clotting Time and Postoperative Transfusions in Cardiac Surgery Outcome

Author(s)
Muhammad Arslan Zahid Department of Anaesthesia, The Aga Khan University Hospital,Karachi,Pakistan
Syed Shabbir Ahmed Department of Anaesthesia, The Aga Khan University Hospital,Karachi,Pakistan
Muhammad Saad Yousuf Department of Anaesthesia, The Aga Khan University Hospital,Karachi,Pakistan
Sadique Ali Wadho Department of Anaesthesia, The Aga Khan University Hospital,Karachi,Pakistan
Muhammad Irfan Akhtar Department of Anaesthesia, The Aga Khan University Hospital,Karachi,Pakistan
Mohammad Hamid Department of Anaesthesia, The Aga Khan University Hospital,Karachi,Pakistan
Abstract
Objective: To assess the impact of post-protamine neutralisation activated clotting time (ACT) values on postoperative outcomes including chest drain output, transfusion requirements, and CICU stay, in patients undergoing cardiac surgery. Study Design: Observational comparative study. Place and Duration of the Study:Department of Anaesthesiology, The Aga Khan University Hospital, Karachi, Pakistan, from February to August 2023. Methodology: Ethical approval was obtained to collect data from elective cardiac surgery patients charts. A sequential sampling approach analysed the baseline and post-protamine neutralisation ACT values, categorising patients into two groups. Group A maintained ACT within 10% of baseline, while Group B deviated. The outcomes measured included transfusion needs, chest drain output, additional protamine, cardiac intensive care unit (CICU) stay, and postoperative reopening. Statistical analysis included mean, median, frequency, t-test / Mann-Whitney U test, and Chi-square test. Results: The study comprised 101 patients (39 in Group A, 62 in Group B), with similar baseline health. No signi cant di erences were found in tranexamic acid use, CICU stay, chest drain output, or transfusion rates between the groups (p >0.05). Conclusion: Maintaining ACT within 10% of baseline post-protamine neutralisation results in similar intraoperative and postoperative outcomes, suggesting potential bene ts in avoiding the aggressive protamine therapy and ensuring haemostasis in cardiac surgery.
Publication Details
Page(s) 1275-1280
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 34, Issue: 11, Year: 2024

Request the full text from PASTIC

Keywords
Coronary Artery Bypass Grafting, Heparin, Cardiopulmonary bypass, Blood transfusions, postoperative bleeding, Activated clotting time (ACT)
0

Citations

0

Downloads

80

Views